The novel approach of tirzepatide peptide represents a major breakthrough in the care of type 2 diabetes. Distinct from existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide355120.wssblogs.com/41965233/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment